These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 32346794

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.
    Kim DW, Kim HJ, Kim KW, Byun JH, Song KB, Kim JH, Hong SM.
    Eur Radiol; 2015 May; 25(5):1375-83. PubMed ID: 25465713
    [Abstract] [Full Text] [Related]

  • 3. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
    Wang Y, Hu X, Shi S, Song C, Wang L, Yuan J, Lin Z, Cai H, Feng ST, Luo Y.
    AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY, Pan Y, Chen JY, Liu LL, Yang YB, Li K, Yu RS, Shao GL.
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [Abstract] [Full Text] [Related]

  • 5. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C, Zhuge X, Wang Z, Wang Q, Sun K, Feng Z, Chen X.
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [Abstract] [Full Text] [Related]

  • 6. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G, Belousova E, Schima W, Glotov A, Kalinin D, Kriger A.
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [Abstract] [Full Text] [Related]

  • 7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, Kanetsuki I, Yoshiura T.
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [Abstract] [Full Text] [Related]

  • 8. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK, Wang M, Yuan J, Song ZG.
    Zhonghua Zhong Liu Za Zhi; 2017 Aug 23; 39(8):600-606. PubMed ID: 28835083
    [Abstract] [Full Text] [Related]

  • 9. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH, Basturk O, Sue JJ, Klimstra DS.
    Am J Surg Pathol; 2016 Sep 23; 40(9):1192-202. PubMed ID: 27259015
    [Abstract] [Full Text] [Related]

  • 10. Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma.
    Azoulay A, Cros J, Vullierme MP, de Mestier L, Couvelard A, Hentic O, Ruszniewski P, Sauvanet A, Vilgrain V, Ronot M.
    Diagn Interv Imaging; 2020 Dec 23; 101(12):821-830. PubMed ID: 32709455
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S, Chen X, Wang Z, Zhao R, Wang J, Cui W, Wang Z.
    PLoS One; 2019 Dec 23; 14(2):e0211566. PubMed ID: 30707733
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S.
    Eur J Radiol; 2015 Nov 23; 84(11):2103-9. PubMed ID: 26321494
    [Abstract] [Full Text] [Related]

  • 13. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP, Baumgartner K, Hepp T, Bitzer M, Horger M.
    Abdom Radiol (NY); 2020 Mar 23; 45(3):750-758. PubMed ID: 31953587
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
    Ren S, Chen X, Wang J, Zhao R, Song L, Li H, Wang Z.
    Abdom Radiol (NY); 2019 Mar 23; 44(3):867-876. PubMed ID: 30293109
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.
    Kim DW, Kim HJ, Kim KW, Byun JH, Kim SY, Song KB, Ramaiya NH, Tirumani SH, Hong SM.
    Eur Radiol; 2016 May 23; 26(5):1320-9. PubMed ID: 26253259
    [Abstract] [Full Text] [Related]

  • 16. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
    Zhu L, Dai MH, Wang ST, Jin ZY, Wang Q, Denecke T, Hamm B, Xue HD.
    Eur J Radiol; 2018 Aug 23; 105():8-14. PubMed ID: 30017302
    [Abstract] [Full Text] [Related]

  • 17. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R.
    Oncologist; 2018 Apr 23; 23(4):422-432. PubMed ID: 29330208
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R, Burk KS, Parakh A, Sahani DV.
    AJR Am J Roentgenol; 2018 Feb 23; 210(2):341-346. PubMed ID: 29140113
    [Abstract] [Full Text] [Related]

  • 19. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK, Lee JM, Joo I, Lee ES, Park HJ, Jang JY, Ryu JK, Lee KB, Han JK.
    Radiology; 2017 Jul 23; 284(1):77-87. PubMed ID: 28092495
    [Abstract] [Full Text] [Related]

  • 20. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E, Dursun N, Ozyalvacli G, Hacihasanoglu E, Behzatoglu K, Calay O.
    Ann Diagn Pathol; 2015 Apr 23; 19(2):81-7. PubMed ID: 25702616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.